SIM
CLRB icon

Sonora Investment Management’s Cellectar Biosciences CLRB Stock Holding History

Sonora Investment Management’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2
Closed -$1K – 1731
2019
Q2 		$1K Hold
2
– – ﹤0.01% 1629
2019
Q1 		$1K Hold
2
– – ﹤0.01% 1435
2018
Q4 		$1K Hold
2
– – ﹤0.01% 1192
2018
Q3 		$2K Hold
2
– – ﹤0.01% 1116
2018
Q2 		$3K Hold
2
– – ﹤0.01% 1020
2018
Q1 		$5.67K Hold
2
– – ﹤0.01% 923
2017
Q4 		$6.85K Hold
2
– – ﹤0.01% 906
2017
Q3 		$8.35K Buy
+2
New +$9.69K ﹤0.01% 774

Other funds holding CLRB

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Sonora Investment Management's CLRB Position: Q3 2019 in Review

Sonora Investment Management sold out of Cellectar Biosciences (CLRB) in Q3 2019, closing a stake of 2 shares — an estimated $1K sold.

Sonora Investment Management first reported a position in CLRB in Q3 2017 and held it in 8 quarters. The position peaked at $8.35K in Q3 2017. 12 funds tracked by Wall St. Rank hold CLRB as of Q3 2019.

  • Sonora Investment Management reported no remaining Cellectar Biosciences position as of Q3 2019 after selling out during the quarter.
  • Sonora Investment Management sold 2 Cellectar Biosciences shares in Q3 2019, an estimated $1K.
  • Sonora Investment Management first reported a position in Cellectar Biosciences in Q3 2017 and held it in 8 quarters.
  • Sonora Investment Management's Cellectar Biosciences position peaked at $8.35K in Q3 2017.
  • 12 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q3 2019.

Based on Sonora Investment Management's 13F filing for Q3 2019, filed 15 Oct 2019.